IUS2:XETRA:XETRA-iShares S&P U.S. Banks UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 4.7695

Change

-0.09 (-1.84)%

Market Cap

USD 0.33B

Volume

0.03M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-05 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.75 (+1.44%)

USD 501.76B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.25 (+1.48%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.37 (+1.36%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.38 (+1.35%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.34 (+1.38%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

+2.74 (+1.90%)

USD 101.19B
JARI:XETRA Amundi Index Solutions - Amund..

+0.84 (+1.80%)

USD 100.74B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.74 (+1.44%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.59 (+0.61%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+3.46 (+0.63%)

USD 80.38B

ETFs Containing IUS2:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.18% 47% F 51% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.18% 47% F 49% F
Trailing 12 Months  
Capital Gain 28.20% 86% B+ 85% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 28.20% 86% B+ 84% B
Trailing 5 Years  
Capital Gain 16.13% 42% F 47% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.13% 41% F 44% F
Average Annual (5 Year Horizon)  
Capital Gain 9.24% 72% C 69% C-
Dividend Return 9.24% 71% C- 67% D+
Total Return N/A 39% F 50% F
Risk Return Profile  
Volatility (Standard Deviation) 37.72% 7% C- 13% F
Risk Adjusted Return 24.50% 43% F 44% F
Market Capitalization 0.33B 58% F 52% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.